Evaluating the Symbicort Turbuhaler [Formoterol/Budesonide] Maintenance and Reliever Therapy for Asthma in Daily Practice.

Trial Profile

Evaluating the Symbicort Turbuhaler [Formoterol/Budesonide] Maintenance and Reliever Therapy for Asthma in Daily Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2009

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 16 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top